Sexual dysfunction and distress in patients with depressive disorders at a tertiary care hospital in Riyadh, Saudi Arabia: a cross-sectional study.
Authors: Almadani AH, Aljaffer MA, Alshammari NF, Alsaber NS, Bin Nujayfan OM, Binbakhit AI, Alenazi ZB, Alruwaili LM, Alshahwan AA, Muhnna AK, Alghamdi AH
Journal: BMC psychiatry
mental health
psychology
open access
Abstract
Research productivity and scientific impact assessment have become increasingly important for understanding the development and contribution of specialized health research areas. Scientometric approaches are widely used to evaluate publication trends, collaboration networks, thematic evolution, institutional productivity, and citation impact across biomedical disciplines [, ]. Within this context, sickle cell disease (SCD) research has attracted growing global attention because of the persistent burden of the disease, particularly in sub‐Saharan Africa, where research evidence is essential for informing policy, clinical practice, and disease management strategies. SCD is one of the most common genetic disorders in Africa [, ] and remains a major cause of morbidity and mortality among affected children []. Globally, SCD continues to pose significant public health challenges, particularly in low‐ and middle‐income countries where access to early diagnosis, specialized care, and long‐term disease management remains limited. In sub‐Saharan Africa, the disease contributes substantially to childhood mortality, chronic illness, reduced quality of life, and socioeconomic hardship among affected individuals and families [, ]. Tanzania is among the five African countries with the highest annual number of newborns affected by SCD (Makani et al., 2018). [] Although SCD has been incorporated into Tanzania′s noncommunicable disease (NCD) management strategy [], it continues to impose considerable clinical, social, and economic burdens on individuals, households, and the healthcare system. Recognizing SCD as a national public health priority, Tanzania established the Muhimbili Sickle Cell (MSC) Program in 2004 to generate country‐specific evidence on disease burden, morbidity, mortality, and clinical management. The program has made substantial contributions to research on the epidemiology, genetics, and clinical manifestations of SCD, including genome‐wide associations between fetal hemoglobin levels and clinical outcomes [–]. These efforts have produced an expanding body of scientific publications involving Tanzanian researchers and institutions, reflecting increasing national and international interest in understanding disease mechanisms, improving patient care, and informing evidence‐based policy and practice. SCD research also spans multiple disciplines, including medicine, immunology, genetics, hematology, and biochemistry [, ], making it well suited for scientometric assessment of publication patterns, collaboration networks, thematic development, and research influence.